000 01346 a2200349 4500
005 20250513164105.0
264 0 _c19990429
008 199904s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/s0264-410x(98)00154-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHopkins, W J
245 0 0 _aAssociation of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection.
_h[electronic resource]
260 _bVaccine
_cJan 1999
300 _a169-71 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBacterial Infections
_xgenetics
650 0 4 _aBacterial Vaccines
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHLA Antigens
_xgenetics
650 0 4 _aHLA-DR2 Antigen
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunity, Mucosal
_xgenetics
650 0 4 _aImmunogenetics
650 0 4 _aPhenotype
650 0 4 _aUrinary Tract Infections
_xgenetics
650 0 4 _aVagina
_ximmunology
700 1 _aHeisey, D M
700 1 _aUehling, D T
773 0 _tVaccine
_gvol. 17
_gno. 2
_gp. 169-71
856 4 0 _uhttps://doi.org/10.1016/s0264-410x(98)00154-6
_zAvailable from publisher's website
999 _c9948563
_d9948563